ImmuCell Corp. (ICCC)
10.25
-0.19
(-1.82%)
USD |
NASDAQ |
Oct 23, 16:00
10.25
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Price : 10.25 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 10.36 | 10.37 | 10.19 | 10.25 | 11335.00 |
| Oct 22, 2026 | 10.44 | 10.44 | 10.26 | 10.44 | 5772.00 |
| Oct 21, 2026 | 10.50 | 10.61 | 10.40 | 10.52 | 7128.00 |
| Oct 20, 2026 | 10.50 | 10.50 | 10.42 | 10.45 | 4195.00 |
| Oct 19, 2026 | 10.67 | 10.67 | 10.50 | 10.51 | 6525.00 |
| Oct 16, 2026 | 10.78 | 10.78 | 10.57 | 10.75 | 2902.00 |
| Oct 15, 2026 | 10.45 | 10.88 | 10.45 | 10.56 | 9871.00 |
| Oct 14, 2026 | 10.80 | 10.80 | 10.50 | 10.75 | 9405.00 |
| Oct 13, 2026 | 10.79 | 10.80 | 10.15 | 10.79 | 51235.00 |
| Oct 12, 2026 | 9.75 | 9.803 | 9.60 | 9.60 | 11160.00 |
| Oct 09, 2026 | 9.75 | 9.80 | 9.65 | 9.80 | 1860.00 |
| Oct 08, 2026 | 9.74 | 9.85 | 9.650 | 9.75 | 5099.00 |
| Oct 07, 2026 | 9.96 | 9.987 | 9.69 | 9.69 | 5160.00 |
| Oct 06, 2026 | 9.931 | 9.97 | 9.931 | 9.97 | 832.00 |
| Oct 05, 2026 | 9.75 | 9.80 | 9.67 | 9.75 | 11262.00 |
| Oct 02, 2026 | 9.80 | 9.80 | 9.61 | 9.75 | 5809.00 |
| Oct 01, 2026 | 9.80 | 9.80 | 9.551 | 9.60 | 39532.00 |
| Sep 30, 2026 | 9.885 | 9.90 | 9.735 | 9.80 | 2549.00 |
| Sep 29, 2026 | 9.92 | 10.10 | 9.92 | 9.94 | 2941.00 |
| Sep 28, 2026 | 9.78 | 10.11 | 9.69 | 9.88 | 4452.00 |
| Sep 25, 2026 | 9.96 | 9.96 | 9.670 | 9.925 | 5051.00 |
| Sep 24, 2026 | 9.96 | 10.08 | 9.96 | 9.97 | 2126.00 |
| Sep 23, 2026 | 10.03 | 10.07 | 9.85 | 9.99 | 7866.00 |
| Sep 22, 2026 | 10.10 | 10.10 | 9.805 | 9.99 | 36073.00 |
| Sep 21, 2026 | 9.80 | 10.16 | 9.74 | 10.13 | 3184.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| PE Ratio | 122.32 |
| PS Ratio | 3.035 |
| Price to Book Value | 2.967 |
| Price to Free Cash Flow | 22.09 |
| Earnings Yield | 0.82% |
| Market Cap | 93.09M |
| Operating PE Ratio | 49.88 |
| Normalized PE Ratio | 74.33 |